Clinical trial
Assessment of Real-life Patient Handling Experience of AVT02 Administered Subcutaneous With an Auto-Injector in Patients With Moderate to Severe Active RA
NCT04224194 is registered in ClinicalTrials.gov with Alvotech Swiss AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Real-life Patient Handling Experience of AVT02 Administered Subcutaneous With an Auto-Injector in Patients With Moderate to Severe Active RA
- Lead sponsor
- Alvotech Swiss AG
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 4, 2019
- Completion date
- February 26, 2021
- Enrollment
- 107 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
ra